IVIRMA Global Research Alliance, IVIRMA Vigo, Reproductive Medicine, Vigo, Spain; Department of Obstetrics and Gynecology, Universidad del Cauca, Popayán, Colombia.
IVIRMA Global Research Alliance, IVIRMA Vigo, Reproductive Medicine, Vigo, Spain.
Fertil Steril. 2023 Oct;120(4):850-859. doi: 10.1016/j.fertnstert.2023.06.029. Epub 2023 Jun 29.
To evaluate live-birth rates per embryo transfer in patients with uterine Müllerian anomalies (UMAs). Secondary objectives were to compare reproductive outcomes between the normal uterus group, the different UMA types, and UMA subgroups with and without required surgery.
This retrospective study compared two cohorts, one with UMAs and other with normal uteri of our oocyte donation program at 12 Instituto Valenciano De Infertilidad/Reproductive Medicine Associates University affiliated clinics from January 2000 to 2020. The oocyte donation reduces confounding because of differences in embryo quality. The primary outcome was the live-birth rate per embryo transfer. Secondary outcomes included the rates of implantation, clinical pregnancy, miscarriage, and ongoing pregnancy. We calculated odds ratios with 95% confidence intervals.
Infertile women undergoing oocyte donation with UMAs.
None.
The rates of implantation, clinical pregnancy, miscarriage, ongoing pregnancy, and live birth.
We analyzed 58,337 cycles of oocyte donation: 57,869 patients had no uterine malformation, and 468 women had UMAs. Compared with patients with normal uteri, patients with UMAs had lower rates of live births (36.67% [32.84-40.65] vs. 38.1% [95% confidence intervals {CI}: 37.82-38.42]) and ongoing pregnancy (39.74% [35.93-43.66] vs. 41.5% [41.24-41.83]). The miscarriage rate was higher in patients with UMAs (19.5% [16.55-22.85] vs. 16.6% [16.47-16.92]). Specifically, patients with a unicornuate uterus (n=29) had lower rates of implantation (24.07% [13.49-37.64] vs. 42.85% [95% CI: 42.6-43.09]), pregnancy (41.86% [27.01-57.87] vs. 59.51% [59.22-59.81]), ongoing pregnancy (16.67% [6.97-31.36] vs. 41.54% [41.24-41.83]), and live births (16.67% [6.97-31.36] vs. 38.12% [37.83-38.42]). In addition, patients with a partial septate uterus (n=91) had a higher miscarriage rate (26.50% [18.44-34.89] vs. 16.7% [16.47-16.92]). Compared with the normal uterus group, the live-birth rates were lower in the UMA without surgery group (33.09% [27.59-38.96] vs. 38.12% [37.83-38.42]).
Among patients who received embryos derived from donated oocytes, live birth and ongoing pregnancy rates were lower in patients with UMAs compared with patients with normal uteri. A higher miscarriage rate was found in patients with UMAs. Patients with a unicornuate uterus had worse reproductive outcomes. Our results show that the uterus is less competent in patients with UMAs.
This study was registered at clinicaltrial.gov (NCT04571671).
评估患有子宫 Müllerian 异常(UMAs)的患者胚胎移植后的活产率。次要目标是比较正常子宫组、不同 UMA 类型以及有或无必需手术的 UMA 亚组之间的生殖结局。
本回顾性研究比较了两个队列,一个是我们的卵母细胞捐赠计划的 12 个 Instituto Valenciano De Infertilidad/Reproductive Medicine Associates 大学附属诊所的 UMA 患者队列,另一个是正常子宫患者队列,时间范围为 2000 年 1 月至 2020 年。卵母细胞捐赠可以减少因胚胎质量差异而导致的混杂因素。主要结局是胚胎移植后的活产率。次要结局包括种植率、临床妊娠率、流产率和持续妊娠率。我们计算了 95%置信区间的优势比。
接受卵母细胞捐赠且患有 UMA 的不孕女性。
无。
种植率、临床妊娠率、流产率、持续妊娠率和活产率。
我们分析了 58337 个卵母细胞捐赠周期:57869 例患者无子宫畸形,468 例患者患有 UMA。与正常子宫患者相比,UMA 患者的活产率较低(36.67% [32.84-40.65] vs. 38.1% [95%置信区间(CI):37.82-38.42])和持续妊娠率(39.74% [35.93-43.66] vs. 41.5% [41.24-41.83])。UMA 患者的流产率较高(19.5% [16.55-22.85] vs. 16.6% [16.47-16.92])。具体来说,单角子宫患者(n=29)的种植率较低(24.07% [13.49-37.64] vs. 42.85% [95% CI:42.6-43.09])、妊娠率(41.86% [27.01-57.87] vs. 59.51% [59.22-59.81])、持续妊娠率(16.67% [6.97-31.36] vs. 41.54% [41.24-41.83])和活产率(16.67% [6.97-31.36] vs. 38.12% [37.83-38.42])较低。此外,部分纵隔子宫患者(n=91)的流产率较高(26.50% [18.44-34.89] vs. 16.7% [16.47-16.92])。与正常子宫组相比,未经手术的 UMA 组的活产率较低(33.09% [27.59-38.96] vs. 38.12% [37.83-38.42])。
在接受捐赠卵母细胞胚胎的患者中,与正常子宫患者相比,UMA 患者的活产率和持续妊娠率较低。UMA 患者的流产率较高。单角子宫患者的生殖结局较差。我们的研究结果表明,UMA 患者的子宫功能较差。
本研究在 clinicaltrial.gov 注册(NCT04571671)。